The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

The pandemic spurred innovation in a variety of ways, from CRISPR-based diagnostics to cell biology benchwork at home.

Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

Our list of the best and brightest products that 2011 had to offer the life scientist

Stock market declines have taken their toll on established firms, but startup ventures still attract backing Launching a new biotechnology company calls for a number of key ingredients, as any wide-eyed scientist who has tested the entrepreneurial waters will attest. You need your enlightened concept, of course, and the enduring visionary force that eventually is to hammer your concept into shape as a viable product. You also need the right people--and the proper blend of them--to keep the

From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

The Scientist has asked a group of experts to comment periodically upon recent articles that they have found noteworthy. Their selections, presented herein every issue, are neither endorsements of content nor the result of systematic searching. Rather, the list represents personal choices of articles the columnists believe the scientific community as a whole may also find interesting. Reprints of any articles cited here may be ordered through The Genuine Article, 3501 Market St., Philadelphia,

Dorothy Rodmann, a career-services consultant at the Washington, D.C.-based American Chemical Society (ACS), is seeing transitioning becoming a necessity for an increasing number of chemists. "In light of what has been happening in the job market -downsizing and strategic changes in direction [among chemical companies]--many chemists are looking at ways to move in different directions, and use their chemical knowledge and skills, of

Dorothy Rodmann, a career-services consultant at the Washington, D.C.-based American Chemical Society (ACS), is seeing transitioning becoming a necessity for an increasing number of chemists. "In light of what has been happening in the job market -downsizing and strategic changes in direction [among chemical companies]--many chemists are looking at ways to move in different directions, and use their chemical knowledge and skills, of

See rebuttal to this article. Scientific publishing is undergoing a profound change. Large and small, commercial and nonprofit publishers are beginning to shift journal delivery from paper to electronic and from library shelves to users' desktops. Without question, the electronic age is speeding up information access. For example, from a computer desktop in his or her office, a subscriber to the online edition of the Journal of Biological Chemistry (JBC) can browse the latest issue shortly af